Sex differences in the course of schizophrenia across diverse regions of the world

by Novick D, Montgomery W, Treuer T, Moneta MV, Haro JM
Published 2016-11-01

LRRK2 expression is enriched in the striosomal compartment of mouse striatum

by Wim Mandemakers, An Snellinx, Michael J. O'Neill, Bart de Strooper
Published 2012-12-01

Health Care Resource Utilization and Costs among Adult Patients with Advanced Soft Tissue Sarcoma: A Retrospective Medical Record Review in the United Kingdom, Spain, Germany, and...

by Daniel S. Mytelka, Saurabh P. Nagar, Yulia D’yachkova, Elizabeth M. La, James A. Kaye, Sean D. Candrilli, Bernd Kasper, Jose Antonio Lopez-Martin, Maria Lorenzo
Published 2018-01-01

Epidemiology of Adult Soft-Tissue Sarcomas in Germany

by Catherine W. Saltus, Brian Calingaert, Sean Candrilli, Maria Lorenzo, Yulia D’yachkova, Thorsten Otto, Uwe Wagner, James A. Kaye
Published 2018-01-01

Cost-effectiveness analysis of baricitinib versus adalimumab for the treatment of moderate-to-severe rheumatoid arthritis in Spain

by Schlueter M, Finn E, Díaz S, Dilla T, Inciarte-Mundo J, Fakhouri W
Published 2019-06-01

The use of random-effects models to identify health care center-related characteristics modifying the effect of antipsychotic drugs

by Nordon C, Battin C, Verdoux H, Haro JM, Belger M, Abenhaim L, van Staa TP
Published 2017-12-01

Clinical development of galunisertib (LY2157299 monohydrate), a small molecule inhibitor of transforming growth factor-beta signaling pathway

by Herbertz S, Sawyer JS, Stauber AJ, Gueorguieva I, Driscoll KE, Estrem ST, Cleverly AL, Desaiah D, Guba SC, Benhadji KA, Slapak CA, Lahn MM
Published 2015-08-01

Treatment Patterns and Pharmacoutilization in Patients Affected by Rheumatoid Arthritis in Italian Settings

by Valentina Perrone, Serena Losi, Veronica Rogai, Silvia Antonelli, Walid Fakhouri, Massimo Giovannitti, Elisa Giacomini, Diego Sangiorgi, Luca Degli Esposti
Published 2021-05-01

Efficacy and safety of biologics in psoriatic arthritis: a systematic literature review and network meta-analysis

by Adeline Ruyssen-Witrand, Richard Perry, Clare Watkins, George Braileanu, Sandeep Kiri, Debby Nott, Soyi Liu-Leage, Susanne Hartz, Christophe Sapin
Published 2020-05-01

Derivation of cutoffs for the Elecsys® amyloid β (1–42) assay in Alzheimer's disease

by Leslie M. Shaw, Teresa Waligorska, Leona Fields, Magdalena Korecka, Michal Figurski, John Q. Trojanowski, Udo Eichenlaub, Simone Wahl, Marian Quan, Michael J. Pontecorvo, D. Richard Lachno, Jayne A. Talbot, Scott W. Andersen, Eric R. Siemers, Robert A. Dean
Published 2018-01-01

Is ramucirumab and paclitaxel therapy beneficial for second-line treatment of metastatic gastric or junctional adenocarcinoma for patients with ascites? Analysis of RAINBOW phase 3...

by Muro K, Jen MH, Cheng R
Published 2019-03-01

Dosing of U-100 insulin and associated outcomes among Medicare enrollees with type 1 or type 2 diabetes

by Eby EL, Van Brunt K, Brusko C, Curtis B, Lage MJ
Published 2015-06-01

Health state utilities associated with adult attention-deficit/hyperactivity disorder

by Matza LS, Devine MK, Haynes VS, Davies EW, Kostelec JM, Televantou F, Jordan JB
Published 2014-07-01

Long-term functional improvements in the 2-year treatment of schizophrenia outpatients with olanzapine long-acting injection

by Ascher-Svanum H, Novick D, Haro JM, Bertsch J, McDonnell D, Detke H
Published 2014-06-01

Comparison of clinical outcomes with orodispersible versus standard oral olanzapine tablets in nonadherent patients with schizophrenia or bipolar disorder

by Novick D, Montgomery W, Treuer T, Koyanagi A, Aguado J, Kraemer S, Haro JM
Published 2017-06-01

Clinical outcomes with olanzapine long-acting injection: impact of the 3-hour observation period on patient satisfaction and well-being

by Anand E, Berggren L, Landry J, Tóth Á, Detke HC
Published 2016-10-01

Do concomitant pain symptoms in patients with major depression affect quality of life even when taking into account baseline depression severity?

by Novick D, Montgomery W, Kadziola Z, Moneta V, Peng X, Brugnoli R, Haro JM
Published 2013-05-01

Cost-Effectiveness of Olaratumab in Combination with Doxorubicin for Patients with Soft Tissue Sarcoma in the United States

by Santiago Zuluaga-Sanchez, Lisa M. Hess, Sorrel E. Wolowacz, Yulia D’yachkova, Emma Hawe, Adrian D. Vickers, James A. Kaye, David Bertwistle
Published 2018-01-01

A Quantitative Systems Pharmacology Consortium Approach to Managing Immunogenicity of Therapeutic Proteins

by Andrzej M. Kierzek, Timothy P. Hickling, Isabel Figueroa, J. Cory Kalvass, Marjoleen Nijsen, Krithika Mohan, Geertruida M. Veldman, Akihiro Yamada, Hiroyuki Sayama, Sachiko Yokoo, Abhishek Gulati, Renu S. Dhanikula, Jochem Gokemeijer, Tarek A. Leil, Craig J. Thalhauser, Mario Giorgi, Maciej J. Swat, Vijayalakshmi Chelliah, Ben G. Small, Neil Benson, Michael Walker, Kapil Gadkar, Valerie Quarmby, Rong Deng, Andrea Ferrante, Gemma L. Dickinson, Jan‐Stefan Van Der Walt, Lian Zhou, Xiaoying Chen, Hannah M. Jones, Jatin Narula, Sophie Tourdot, Thierry Lavé, Benjamin Ribba, Piet H. van derGraaf
Published 2019-11-01

Predictors and consequences of adherence to the treatment of pediatric patients with attention-deficit/hyperactivity disorder in Central Europe and East Asia

by Hong J, Novick D, Treuer T, Montgomery W, Haynes VS, Wu S, Haro JM
Published 2013-09-01